Arrowhead Pharmaceuticals, Inc. (ARWR) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$57.07
Day's range
$60.97

Arrowhead Pharmaceuticals Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 02/12/2026 21.32 M $1.42 B   5.41% 15.22%
VANGUARD GROUP INC 01/29/2026 15.29 M $1.02 B   -4.63% 10.92%
AVORO CAPITAL ADVISORS LLC 03/16/2026 10.63 M $705.39 M   -2.52% 7.59%
FMR LLC 02/17/2026 6.52 M $432.89 M   13.20% 4.66%
STATE STREET CORP 02/13/2026 6.40 M $425.15 M   0.10% 4.57%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 3.26 M $216.80 M   4.28% 2.33%
SLATE PATH CAPITAL LP 02/17/2026 2.52 M $167.54 M   -49.35% 1.80%
BAKER BROS. ADVISORS LP 02/17/2026 2.18 M $144.44 M   30.22% 1.55%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 02/13/2026 2.09 M $138.62 M   0.30% 1.49%
FRED ALGER MANAGEMENT, LLC 02/17/2026 1.83 M $121.69 M   497.39% 1.31%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 02/17/2026 1.83 M $121.69 M   84.59% 1.31%
DRIEHAUS CAPITAL MANAGEMENT LLC 02/17/2026 1.77 M $117.47 M   -15.72% 1.26%
NORGES BANK 02/10/2026 1.70 M $113.16 M   100.00% 1.22%
GOLDMAN SACHS GROUP INC 03/25/2026 1.68 M $111.37 M   -5.43% 1.20%
SIREN, L.L.C. 02/13/2026 1.50 M $99.62 M   -43.80% 1.07%
MORGAN STANLEY 02/13/2026 1.48 M $97.99 M   -13.31% 1.05%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 1.35 M $89.87 M   0.58% 0.97%
NORTHERN TRUST CORP 02/17/2026 1.35 M $89.38 M   2.64% 0.96%
FISHER ASSET MANAGEMENT, LLC 02/09/2026 1.31 M $87.09 M   24.48% 0.94%
JANUS HENDERSON GROUP PLC 02/17/2026 1.28 M $85.00 M   31.52% 0.91%
UBS ASSET MANAGEMENT AMERICAS INC 02/13/2026 1.26 M $83.68 M   -28.37% 0.90%
PICTET ASSET MANAGEMENT HOLDING SA 01/29/2026 1.03 M $68.64 M   253.49% 0.76%
UBS GROUP AG 01/29/2026 987.29 K $65.55 M   7.53% 0.71%
VESTAL POINT CAPITAL, LP 02/17/2026 900.00 K $59.75 M   100.00% 0.64%
BANK OF NEW YORK MELLON CORP 02/10/2026 887.85 K $58.94 M   9.00% 0.63%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 859.90 K $57.09 M   61.00% 0.61%
WESTERN FINANCIAL CORP/CA 01/21/2026 820.24 K $54.46 M   0.00% 0.60%
PRICE T ROWE ASSOCIATES INC /MD/ 02/17/2026 838.82 K $55.69 M   660.87% 0.60%
PRINCIPAL FINANCIAL GROUP INC 02/02/2026 715.54 K $47.50 M   -8.28% 0.53%
ASSENAGON ASSET MANAGEMENT S.A. 01/09/2026 684.89 K $45.47 M   79.94% 0.50%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 02/10/2026 663.26 K $44.03 M   432.62% 0.47%
JPMORGAN CHASE & CO 02/11/2026 611.91 K $40.62 M   -21.12% 0.46%
BANK OF AMERICA CORP /DE/ 02/17/2026 622.03 K $41.30 M   -18.23% 0.44%
RTW INVESTMENTS, LP 02/17/2026 584.72 K $38.82 M   100.00% 0.42%
ADAGE CAPITAL PARTNERS GP, L.L.C. 02/17/2026 550.00 K $36.51 M   100.00% 0.39%
INVESCO LTD. 02/19/2026 547.76 K $36.37 M   8.92% 0.39%
PUBLIC SECTOR PENSION INVESTMENT BOARD 02/13/2026 478.51 K $31.77 M   -11.28% 0.34%
CITADEL ADVISORS LLC 02/17/2026 474.26 K $31.49 M   49.32% 0.34%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 02/17/2026 470.00 K $31.20 M   100.00% 0.34%
VOYA INVESTMENT MANAGEMENT LLC 02/12/2026 422.73 K $28.07 M   207.41% 0.30%
PRIVIUM FUND MANAGEMENT B.V. 02/03/2026 398.20 K $26.44 M   -15.98% 0.29%
WOODLINE PARTNERS LP 02/17/2026 400.18 K $26.57 M   -59.99% 0.29%
LEGAL & GENERAL GROUP PLC 02/09/2026 395.31 K $26.24 M   2.31% 0.28%
BALYASNY ASSET MANAGEMENT L.P. 02/17/2026 376.22 K $24.98 M   -52.56% 0.27%
ALYESKA INVESTMENT GROUP, L.P. 02/13/2026 375.37 K $24.92 M   100.00% 0.27%
EVENTIDE ASSET MANAGEMENT, LLC 02/13/2026 370.00 K $24.56 M   100.00% 0.26%
RHUMBLINE ADVISERS 02/13/2026 352.40 K $23.40 M   -5.04% 0.25%
NORDEA INVESTMENT MANAGEMENT AB 01/08/2026 324.25 K $21.57 M   -12.90% 0.24%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 331.50 K $22.01 M   107.84% 0.24%
BARCLAYS PLC 02/13/2026 321.83 K $21.37 M   -8.11% 0.23%

Arrowhead Pharmaceuticals Inc. institutional Ownership - FAQ's

During the previous two years, 560 institutional investors and hedge funds held shares of Arrowhead Pharmaceuticals Inc.. The most heavily invested institutionals were:

Invesco Ltd.: 3.28 M

UBS Group AG: 1.34 M

Pictet Asset Management Holding SA: 1.27 M

Fisher Asset Management, LLC: 1.11 M

VANGUARD FIDUCIARY TRUST CO: 965,775

Bank of New York Mellon Corp: 960,144

82.82% of Arrowhead Pharmaceuticals Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 160.38 M shares in the last 24 months. This purchase volume represents approximately $9.73 B in transactions.